CoChat

Gastro-oesophageal reflux disease

Open access
Fass, Ronnie, Boeckxstaens, Guy E., El-Serag, Hashem, Rosen, Rachel, Sifrim, Daniel, Vaezi, Michael F. · 2021 · Nature Reviews Disease Primers
Cited by 237

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41572-021-00287-w

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 343

  1. Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J. & Jones, R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 101, 1900–1920 (2006). · DOI · Paper page
  2. Vaezi, M. F. Chronic cough and gastroesophageal reflux disease: how do we establish a causal link? Chest 143, 587–589 (2013). · DOI
  3. Naik, R. D. & Vaezi, M. F. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Expert Rev. Gastroenterol. Hepatol. 9, 969–982 (2015). · DOI
  4. Fass, R. & Achem, S. R. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J. Neurogastroenterol. Motil. 17, 110–123 (2011). · DOI · Paper page
  5. Mönnikes, H. et al. Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest in erosive GERD. Digestion 75, 41–47 (2007). · doi:10.1159/000101081
  6. Heading, R. C. et al. Discrepancies between upper GI symptoms described by those who have them and their identification by conventional medical terminology: a survey of sufferers in four countries. Eur. J. Gastroenterol. Hepatol. 28, 455–462 (2016). · doi:10.1097/meg.0000000000000565
  7. Wiklund, I., Carlsson, J. & Vakil, N. Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community. Am. J. Gastroenterol. 101, 18–28 (2006). · DOI
  8. Aro, P. et al. Quality of life in a general adult population with gastroesophageal reflux symptoms and/or esophagitis. A report from the Kalixanda study. Gastroenterology 124, A168 (2003). · doi:10.1016/s0016-5085(03)80835-1
  9. Shaw, M., Adlis, S. & Beebe, T. When does heartburn become a disease. Gastroenterology 114, G1166 (1998).
  10. Fass, R. & Ofman, J. J. Gastroesophageal reflux disease–should we adopt a new conceptual framework? Am. J. Gastroenterol. 97, 1901–1909 (2002). The first paper that challenged the concept that GERD is a spectrum of disease but rather composed of three unique phenotypes.
  11. Modlin, I. M. et al. Non-erosive reflux disease–defining the entity and delineating the management. Digestion 78, 1–5 (2008). · DOI
  12. Yamasaki, T. & Fass, R. Reflux hypersensitivity: a new functional esophageal disorder. J. Neurogastroenterol. Motil. 23, 495–503 (2017). · DOI
  13. Lundell, L. R. et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45, 172–180 (1999). · DOI · Paper page
  14. Gyawali, C. P. et al. Modern diagnosis of GERD: the lyon consensus. Gut 67, 1351–1362 (2018). · DOI · Paper page
  15. Sharma, P. et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131, 1392–1399 (2006). · DOI · Paper page
  16. Fass, R. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics. J. Clin. Gastroenterol. 41, 131–137 (2007). · DOI · Paper page
  17. Hershcovici, T., Jha, L. K. & Fass, R. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease. J. Clin. Gastroenterol. 46, 562–566 (2012). · doi:10.1097/mcg.0b013e318248f631
  18. Dickman, R. et al. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Aliment. Pharmacol. Ther. 26, 41–48 (2007). · DOI
  19. Schey, R. et al. Comparison of the different characteristics of sensed reflux events among different heartburn groups. J. Clin. Gastroenterol. 43, 699–704 (2009). · doi:10.1097/mcg.0b013e318182673f
  20. Shah, A., Shibli, F., Kitayama, Y. & Fass, R. The natural course of gastroesophageal reflux disease: a critical appraisal of the literature. J. Clin. Gastroenterol. 55, 12–20 (2021). · doi:10.1097/mcg.0000000000001419
  21. Smout, A. Endoscopy-negative acid reflux disease. Alimentary Pharmacol. Therapeut. 11, 81–85 (1997). · DOI
  22. Venables, T. et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand. J. Gastroenterol. 32, 965–973 (1997). · DOI · Paper page
  23. Yi, C.-H., Hu, C.-T. & Chen, C.-L. Sleep dysfunction in patients with GERD: erosive versus nonerosive reflux disease. Am. J. Med. Sci. 334, 168–170 (2007). · DOI
  24. Carlsson, R. et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. Eur. J. Gastroenterol. Hepatol. 10, 119–124 (1998). · DOI · Paper page
  25. Eusebi, L. H. et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 67, 430–440 (2018). One of the most updated reviews of the global prevalence of GERD. · DOI · Paper page
  26. El-Serag, H. B., Sweet, S., Winchester, C. C. & Dent, J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63, 871–880 (2014). · DOI · Paper page
  27. Kotzan, J., Wade, W. & Yu, H. H. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm. Res. 18, 1367–1372 (2001). · doi:10.1023/a:1013010616496
  28. Ruigómez, A. et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment. Pharmacol. Ther. 20, 751–760 (2004). · DOI · Paper page
  29. El-Serag, H. B. et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126, 1692–1699 (2004). · DOI · Paper page
  30. Boeckxstaens, G., El-Serag, H. B., Smout, A. J. & Kahrilas, P. J. Symptomatic reflux disease: the present, the past and the future. Gut 63, 1185–1193 (2014). · DOI · Paper page
  31. Shiota, S., Singh, S., Anshasi, A. & El-Serag, H. B. Prevalence of Barrett’s esophagus in asian countries: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 13, 1907–1918 (2015). · DOI
  32. Lembo, A., Zaman, M., Jones, M. & Talley, N. J. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment. Pharmacol. Ther. 25, 1343–1350 (2007). · DOI · Paper page
  33. El-Serag, H. B., Satia, J. A. & Rabeneck, L. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut 54, 11–17 (2005). · DOI · Paper page
  34. Murphy, D. W. & Castell, D. O. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am. J. Gastroenterol. 83, 633–636 (1988).
  35. Nocon, M., Labenz, J. & Willich, S. N. Lifestyle factors and symptoms of gastro-oesophageal reflux – a population-based study. Aliment. Pharmacol. Ther. 23, 169–174 (2006). · DOI · Paper page
  36. Zheng, Z., Nordenstedt, H., Pedersen, N. L., Lagergren, J. & Ye, W. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 132, 87–95 (2007). · DOI · Paper page
  37. Johnson, T., Gerson, L., Hershcovici, T., Stave, C. & Fass, R. Systematic review: the effects of carbonated beverages on gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 31, 607–614 (2010). · DOI · Paper page
  38. Piesman, M., Hwang, I., Maydonovitch, C. & Wong, R. K. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am. J. Gastroenterol. 102, 2128–2134 (2007). · DOI · Paper page
  39. DiSilvestro, R. A., Verbruggen, M. A. & Offutt, E. J. Anti-heartburn effects of a fenugreek fiber product. Phytother. Res. 25, 88–91 (2011). · doi:10.1002/ptr.3229
  40. Kubo, A., Corley, D. A., Jensen, C. D. & Kaur, R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett’s oesophagus. Nutr. Res. Rev. 23, 230–246 (2010). · DOI
  41. Nilsson, M., Johnsen, R., Ye, W., Hveem, K. & Lagergren, J. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 53, 1730–1735 (2004). · DOI · Paper page
  42. Singh, S. et al. Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 11, 1399–1412 (2013). · DOI · Paper page
  43. El-Serag, H. Role of obesity in GORD-related disorders. Gut 57, 281–284 (2008). · doi:10.1136/gut.2007.127878
  44. El-Serag, H. B. et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut 63, 220–229 (2014).
  45. Liska, D. et al. Interethnic differences in muscle, liver and abdominal fat partitioning in obese adolescents. PLoS ONE 2, e569 (2007). · DOI
  46. Yaghoobi, M., Farrokhyar, F., Yuan, Y. & Hunt, R. H. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis. Am. J. Gastroenterol. 105, 1007–1013 (2010). quiz 1006, 1014. · DOI · Paper page
  47. Zhao, Y. et al. The effect of helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies. Dig. Dis. 38, 261–268 (2020). · DOI
  48. Fischbach, L. A. et al. The association between Barrett’s esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter 17, 163–175 (2012). · DOI
  49. Islami, F. & Kamangar, F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev. Res. 1, 329–338 (2008). · DOI · Paper page
  50. El-Serag, H. B. et al. Corpus gastritis is protective against reflux oesophagitis. Gut 45, 181–185 (1999). · DOI
  51. Fischbach, L. A. et al. Association between Helicobacter pylori and Barrett’s esophagus: a case-control study. Am. J. Gastroenterol. 109, 357–368 (2014). · DOI
  52. Havemann, B. D., Henderson, C. A. & El-Serag, H. B. The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 56, 1654–1664 (2007). · DOI · Paper page
  53. Hershcovici, T. et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 34, 1295–1305 (2011). · DOI
  54. Ruhl, C. E., Sonnenberg, A. & Everhart, J. E. Hospitalization with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann. Epidemiol. 11, 477–483 (2001). · DOI
  55. Chitkara, D. K. et al. Incidence of presentation of common functional gastrointestinal disorders in children from birth to 5 years: a cohort study. Clin. Gastroenterol. Hepatol. 5, 186–191 (2007). · DOI
  56. Nelson, S. P., Chen, E. H., Syniar, G. M. & Christoffel, K. K. Prevalence of symptoms of gastroesophageal reflux during infancy. A pediatric practice-based survey. Pediatric Practice Research Group. Arch. Pediatr. Adolesc. Med. 151, 569–572 (1997). · DOI · Paper page
  57. Rosen, R. et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 66, 516–554 (2018). · DOI · Paper page
  58. Orenstein, S. R., Shalaby, T. M. & Cohn, J. F. Reflux symptoms in 100 normal infants: diagnostic validity of the infant gastroesophageal reflux questionnaire. Clin. Pediatr. 35, 607–614 (1996). · doi:10.1177/000992289603501201
  59. Ruigómez, A., Lundborg, P., Johansson, S., Wallander, M. A. & García Rodríguez, L. A. Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis. Scand. J. Gastroenterol. 45, 814–821 (2010). · DOI
  60. El-Serag, H. B., Gilger, M., Carter, J., Genta, R. M. & Rabeneck, L. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am. J. Gastroenterol. 99, 806–812 (2004). · doi:10.1111/j.1572-0241.2004.30098.x
  61. Hirschowitz, B. I. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101, 1149–1158 (1991). · doi:10.1016/0016-5085(91)90062-p
  62. Fletcher, J., Wirz, A., Young, J., Vallance, R. & McColl, K. E. Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal. Gastroenterology 121, 775–783 (2001). · DOI · Paper page
  63. McColl, K. E., Clarke, A. & Seenan, J. Acid pocket, hiatus hernia and acid reflux. Gut 59, 430–431 (2010). · doi:10.1136/gut.2009.192922
  64. Pandolfino, J. E. et al. Acidity surrounding the squamocolumnar junction in GERD patients: “acid pocket” versus “acid film”. Am. J. Gastroenterol. 102, 2633–2641 (2007). · DOI
  65. Clarke, A. T. et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket. Gut 57, 292–297 (2008). · doi:10.1136/gut.2006.109421
  66. Beaumont, H., Bennink, R. J., de Jong, J. & Boeckxstaens, G. E. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut 59, 441–451 (2010). · DOI · Paper page
  67. Stacher, G. et al. Gastric emptying: a contributory factor in gastro-oesophageal reflux activity? Gut 47, 661–666 (2000). · DOI
  68. Penagini, R. et al. Motor function of the proximal stomach and visceral perception in gastro-oesophageal reflux disease. Gut 42, 251–257 (1998). · DOI
  69. Zerbib, F. et al. Proximal gastric tone in gastro-oesophageal reflux disease. Eur. J. Gastroenterol. Hepatol. 11, 511–515 (1999). · DOI
  70. Dodds, W. J. et al. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis. N. Engl. J. Med. 307, 1547–1552 (1982). · DOI · Paper page
  71. Mittal, R. K., Holloway, R. H., Penagini, R., Blackshaw, L. A. & Dent, J. Transient lower esophageal sphincter relaxation. Gastroenterology 109, 601–610 (1995). · DOI · Paper page
  72. Babaei, A., Bhargava, V., Korsapati, H., Zheng, W. H. & Mittal, R. K. A unique longitudinal muscle contraction pattern associated with transient lower esophageal sphincter relaxation. Gastroenterology 134, 1322–1331 (2008). · doi:10.1053/j.gastro.2008.02.031
  73. Mittal, R. K. & McCallum, R. W. Characteristics and frequency of transient relaxations of the lower esophageal sphincter in patients with reflux esophagitis. Gastroenterology 95, 593–599 (1988). · doi:10.1016/s0016-5085(88)80003-9
  74. Sifrim, D. & Holloway, R. Transient lower esophageal sphincter relaxations: how many or how harmful? Am. J. Gastroenterol. 96, 2529–2532 (2001). · DOI
  75. Dent, J., Holloway, R. H., Toouli, J. & Dodds, W. J. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut 29, 1020–1028 (1988). · DOI · Paper page
  76. Schoeman, M. N., Tippett, M. D., Akkermans, L. M., Dent, J. & Holloway, R. H. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology 108, 83–91 (1995). · DOI · Paper page
  77. Penagini, R., Schoeman, M. N., Dent, J., Tippett, M. D. & Holloway, R. H. Motor events underlying gastro-oesophageal reflux in ambulant patients with reflux oesophagitis. Neurogastroenterol. Motil. 8, 131–141 (1996). · DOI
  78. Holloway, R. H. & Dent, J. Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease. Gastroenterol. Clin. North Am. 19, 517–535 (1990). · DOI
  79. van Herwaarden, M. A., Samsom, M. & Smout, A. J. Excess gastroesophageal reflux in patients with hiatus hernia is caused by mechanisms other than transient LES relaxations. Gastroenterology 119, 1439–1446 (2000). · DOI · Paper page
  80. Kahrilas, P. J., Lin, S., Chen, J. & Manka, M. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut 44, 476–482 (1999). · DOI · Paper page
  81. Mittal, R. K. & Balaban, D. H. The esophagogastric junction. N. Engl. J. Med. 336, 924–932 (1997). · DOI · Paper page
  82. Sloan, S. & Kahrilas, P. J. Impairment of esophageal emptying with hiatal hernia. Gastroenterology 100, 596–605 (1991). · DOI · Paper page
  83. DeMeester, T. R. et al. Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J. Thorac. Cardiovascular Surg. 79, 656–670 (1980). · DOI
  84. Frazzoni, M., De Micheli, E. & Savarino, V. Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease. Aliment. Pharmacol. Ther. 18, 1091–1098 (2003). · doi:10.1046/j.1365-2036.2003.01768.x
  85. Bredenoord, A. J., Hemmink, G. J. & Smout, A. J. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage. Neurogastroenterol. Motil. 21, 807–812 (2009). · doi:10.1111/j.1365-2982.2009.01306.x
  86. Bredenoord, A. J., Weusten, B. L., Curvers, W. L., Timmer, R. & Smout, A. J. Determinants of perception of heartburn and regurgitation. Gut 55, 313–318 (2006). · DOI · Paper page
  87. Savarino, E. et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur. Respir. J. 42, 1322–1331 (2013). · DOI · Paper page
  88. Sifrim, D. et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54, 449–454 (2005). · doi:10.1136/gut.2004.055418
  89. Blondeau, K. et al. Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J. Heart Lung Transplant. 28, 141–148 (2009). · DOI
  90. Pauwels, A. et al. Gastric emptying and different types of reflux in adult patients with cystic fibrosis. Aliment. Pharmacol. Ther. 34, 799–807 (2011). · doi:10.1111/j.1365-2036.2011.04786.x
  91. Smith, J. A. et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology 139, 754–762 (2010). · DOI · Paper page
  92. Herregods, T. V. K. et al. Determinants of reflux-induced chronic cough. Gut 66, 2057–2062 (2017). · DOI
  93. Wenzl, T. G. et al. Association of apnea and nonacid gastroesophageal reflux in infants: Investigations with the intraluminal impedance technique. Pediatr. Pulmonol. 31, 144–149 (2001). · doi:10.1002/1099-0496(200102)31:2<144::aid-ppul1023>3.0.co;2-z
  94. Rosen, R. et al. Higher rate of bronchoalveolar lavage culture positivity in children with nonacid reflux and respiratory disorders. J. Pediatr. 159, 504–506 (2011). · doi:10.1016/j.jpeds.2011.05.021
  95. Skopnik, H. et al. Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J. Pediatr. Gastroenterol. Nutr. 23, 591–598 (1996). · doi:10.1097/00005176-199612000-00014
  96. López-Alonso, M. et al. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux. Pediatrics 118, e299–e308 (2006). · DOI · Paper page
  97. Vaezi, M. F. & Richter, J. E. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett’s esophagus. Surgery 117, 699–704 (1995). · doi:10.1016/s0039-6060(95)80015-8
  98. Pace, F., Sangaletti, O., Pallotta, S., Molteni, P. & Porro, G. B. Biliary reflux and non-acid reflux are two distinct phenomena: a comparison between 24-hour multichannel intraesophageal impedance and bilirubin monitoring. Scand. J. Gastroenterol. 42, 1031–1039 (2007). · DOI
  99. Vaezi, M. F. & Richter, J. E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111, 1192–1199 (1996). · DOI · Paper page
  100. Siddiqui, A., Rodriguez-Stanley, S., Zubaidi, S. & Miner, P. B. Jr. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects. Dig. Dis. Sci. 50, 81–85 (2005). · doi:10.1007/s10620-005-1282-0
  101. Farré, R. et al. Short exposure of oesophageal mucosa to bile acids, both in acidic and weakly acidic conditions, can impair mucosal integrity and provoke dilated intercellular spaces. Gut 57, 1366–1374 (2008). · DOI · Paper page
  102. Tack, J., Koek, G., Demedts, I., Sifrim, D. & Janssens, J. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett’s esophagus: acid reflux, bile reflux, or both? Am. J. Gastroenterol. 99, 981–988 (2004). · doi:10.1111/j.1572-0241.2004.04171.x
  103. Gasiorowska, A. et al. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am. J. Gastroenterol. 104, 2005–2013 (2009). · DOI
  104. de Bortoli, N. et al. Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance. Neurogastroenterol. Motil. 32, e13919 (2020). · doi:10.1111/nmo.13919
  105. Emerenziani, S. et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut 57, 443–447 (2008). · DOI
  106. Bredenoord, A. J., Weusten, B. L., Sifrim, D., Timmer, R. & Smout, A. J. Aerophagia, gastric, and supragastric belching: a study using intraluminal electrical impedance monitoring. Gut 53, 1561–1565 (2004). · DOI · Paper page
  107. Hemmink, G. J., Bredenoord, A. J., Weusten, B. L., Timmer, R. & Smout, A. J. Supragastric belching in patients with reflux symptoms. Am. J. Gastroenterol. 104, 1992–1997 (2009). · DOI
  108. Koukias, N., Woodland, P., Yazaki, E. & Sifrim, D. Supragastric belching: prevalence and association with gastroesophageal reflux disease and esophageal hypomotility. J. Neurogastroenterol. Motil. 21, 398–403 (2015). · DOI
  109. Sifrim, D., Silny,, J., Holloway, R. H. & Janssens, J. J. Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 44, 47–54 (1999). · DOI · Paper page
  110. Cicala, M. et al. Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 18, 605–613 (2003). · doi:10.1046/j.1365-2036.2003.01702.x
  111. Weusten, B. L., Akkermans, L. M., vanBerge-Henegouwen, G. P. & Smout, A. J. Symptom perception in gastroesophageal reflux disease is dependent on spatiotemporal reflux characteristics. Gastroenterology 108, 1739–1744 (1995). · DOI
  112. Zerbib, F., Duriez, A., Roman, S., Capdepont, M. & Mion, F. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut 57, 156–160 (2008). · doi:10.1136/gut.2007.133470
  113. Rohof, W. O., Bennink, R. J., de Jonge, H. & Boeckxstaens, G. E. Increased proximal reflux in a hypersensitive esophagus might explain symptoms resistant to proton pump inhibitors in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 12, 1647–1655 (2014). · doi:10.1016/j.cgh.2013.10.026
  114. Tipnis, N. A., Rhee, P. L. & Mittal, R. K. Distension during gastroesophageal reflux: effects of acid inhibition and correlation with symptoms. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G469–G474 (2007). · doi:10.1152/ajpgi.00019.2007
  115. Helm, J. F. et al. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N. Engl. J. Med. 310, 284–288 (1984). · doi:10.1056/nejm198402023100503
  116. Richter, J. E. et al. Relationship of radionuclide liquid bolus transport and esophageal manometry. J. Lab. Clin. Med. 109, 217–224 (1987).
  117. Ribolsi, M., Balestrieri, P., Emerenziani, S., Guarino, M. P. & Cicala, M. Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients. Am. J. Gastroenterol. 109, 46–51 (2014). · DOI
  118. Roman, S., Lin, Z., Kwiatek, M. A., Pandolfino, J. E. & Kahrilas, P. J. Weak peristalsis in esophageal pressure topography: classification and association with Dysphagia. Am. J. Gastroenterol. 106, 349–356 (2011). · DOI · Paper page
  119. Kahrilas, P. J. et al. Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91, 897–904 (1986). · doi:10.1016/0016-5085(86)90692-x
  120. Katzka, D. A. Motility abnormalities in gastroesophageal reflux disease. Gastroenterol. Clin. North. Am. 28, 905–915 (1999). · doi:10.1016/s0889-8553(05)70097-2
  121. Ang, D., Blondeau, K., Sifrim, D. & Tack, J. The spectrum of motor function abnormalities in gastroesophageal reflux disease and Barrett’s esophagus. Digestion 79, 158–168 (2009). · doi:10.1159/000210265
  122. Schoeman, M. N. & Holloway, R. H. Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease. Gut 36, 499–504 (1995). · DOI
  123. Mittal, R. K., Lange, R. C. & McCallum, R. W. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology 92, 130–135 (1987). · DOI · Paper page
  124. Shay, S. S., Johnson, L. F. & Richter, J. E. Acid rereflux: a review, emphasizing detection by impedance, manometry, and scintigraphy, and the impact on acid clearing pathophysiology as well as interpreting the pH record. Dig. Dis. Sci. 48, 1–9 (2003). · doi:10.1023/a:1021762310433
  125. Dantas, R. O., Oliveira, R. B., Aprile, L. R., Hara, S. H. & Sifrim, D. A. Saliva transport to the distal esophagus. Scand. J. Gastroenterol. 40, 1010–1016 (2005). · doi:10.1080/00365520510023297
  126. Korsten, M. A. et al. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am. J. Med. 90, 701–706 (1991). · DOI
  127. Chang, C. S., Liao, C. H., Muo, C. H. & Kao, C. H. Increased risk of concurrent gastroesophageal reflux disease among patients with Sjögren’s syndrome: a nationwide population-based study. Eur. J. Intern. Med. 31, 73–78 (2016). · doi:10.1016/j.ejim.2016.01.014
  128. Orr, W. C., Chen, C. L. & Sloan, S. The role of age and salivation in acid clearance in symptomatic patients with gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 15, 1385–1388 (2001). · DOI
  129. Frazzoni, M. et al. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn. Am. J. Gastroenterol. 113, 670–676 (2018). · doi:10.1038/s41395-018-0044-5
  130. Frazzoni, L. et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.13116 (2017). · doi:10.1111/nmo.13116
  131. Tobey, N. A., Carson, J. L., Alkiek, R. A. & Orlando, R. C. Dilated intercellular spaces: a morphological feature of acid reflux–damaged human esophageal epithelium. Gastroenterology 111, 1200–1205 (1996). · DOI · Paper page
  132. Souza, R. F. et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 137, 1776–1784 (2009). The first study to propose that EE is the result of cytokine-mediated inflammation rather than direct mucosal caustic acid injury. · DOI · Paper page
  133. Dunbar, K. B. et al. Association of acute gastroesophageal reflux disease with esophageal histologic changes. JAMA 315, 2104–2112 (2016). · doi:10.1001/jama.2016.5657
  134. Souza, R. F., Bayeh, L., Spechler, S. J., Tambar, U. K. & Bruick, R. K. A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: a potential role for targeting HIF-2α to prevent and treat reflux esophagitis. Curr. Opin. Pharmacol. 37, 93–99 (2017). · DOI
  135. Ustaoglu, A. et al. Mucosal pathogenesis in gastro-esophageal reflux disease. Neurogastroenterol. Motil. 32, e14022 (2020). · DOI
  136. Bytzer, P., van Zanten, S. V., Mattsson, H. & Wernersson, B. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients. Aliment. Pharmacol. Ther. 36, 635–643 (2012). · DOI
  137. Calabrese, C. et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am. J. Gastroenterol. 100, 537–542 (2005). · DOI · Paper page
  138. Woodland, P., Al-Zinaty, M., Yazaki, E. & Sifrim, D. In vivo evaluation of acid-induced changes in oesophageal mucosa integrity and sensitivity in non-erosive reflux disease. Gut 62, 1256–1261 (2013). · doi:10.1136/gutjnl-2012-302645
  139. Kessing, B. F. et al. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am. J. Gastroenterol. 106, 2093–2097 (2011). · doi:10.1038/ajg.2011.276
  140. Wiener, G. J., Richter, J. E., Copper, J. B., Wu, W. C. & Castell, D. O. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am. J. Gastroenterol. 83, 358–361 (1988).
  141. Knowles, C. H. & Aziz, Q. Visceral hypersensitivity in non-erosive reflux disease. Gut 57, 674–683 (2008). · DOI · Paper page
  142. Kollarik, M., Ru, F. & Brozmanova, M. Vagal afferent nerves with the properties of nociceptors. Auton. Neurosci. 153, 12–20 (2010). · DOI
  143. Shi, G., Bruley des Varannes, S., Scarpignato, C., Le Rhun, M. & Galmiche, J. P. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 37, 457–464 (1995). · doi:10.1136/gut.37.4.457
  144. Reeh, P. W. & Kress, M. Molecular physiology of proton transduction in nociceptors. Curr. Opin. Pharmacol. 1, 45–51 (2001). · DOI
  145. Holzer, P. Acid-sensitive ion channels in gastrointestinal function. Curr. Opin. Pharmacol. 3, 618–625 (2003). · DOI
  146. Caterina, M. J. & Julius, D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu. Rev. Neurosci. 24, 487–517 (2001). · DOI · Paper page
  147. Burnstock, G. & Wood, J. N. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6, 526–532 (1996). · DOI · Paper page
  148. Knowles, C. H. & Aziz, Q. Basic and clinical aspects of gastrointestinal pain. Pain 141, 191–209 (2009). · DOI · Paper page
  149. Kirkup, A. J., Brunsden, A. M. & Grundy, D. Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G787–G794 (2001). · DOI · Paper page
  150. Sarkar, S. et al. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression. Am. J. Gastroenterol. 99, 1998–2006 (2004). · DOI
  151. Sarkar, S., Aziz, Q., Woolf, C. J., Hobson, A. R. & Thompson, D. G. Contribution of central sensitisation to the development of non-cardiac chest pain. Lancet 356, 1154–1159 (2000). · DOI · Paper page
  152. Woodland, P. et al. Distinct afferent innervation patterns within the human proximal and distal esophageal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 308, G525–G531 (2015). · DOI
  153. Nikaki, K. et al. Esophageal mucosal innervation in functional heartburn: closer to healthy asymptomatic subjects than to non-erosive reflux disease patients. Neurogastroenterol. Motil. 31, e13667 (2019). · DOI
  154. Woodland, P. et al. Superficial esophageal mucosal afferent nerves may contribute to reflux hypersensitivity in nonerosive reflux disease. Gastroenterology 153, 1230–1239 (2017). A study demonstrating that esophageal hypersensitivity in patients with NERD is the result of sensory afferents that are uniquely situated close to the mucosa. · DOI
  155. Sifrim, D. & Zerbib, F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut 61, 1340–1354 (2012). · DOI · Paper page
  156. Fass, R. et al. The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease. Gastroenterology 134, 696–705 (2008). · DOI
  157. Kessing, B. F., Bredenoord, A. J., Saleh, C. M. & Smout, A. J. Effects of anxiety and depression in patients with gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 13, 1089–1095.e1 (2015). · DOI
  158. Schey, R. et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 133, 1787–1795 (2007). · DOI · Paper page
  159. Farré, R. et al. Critical role of stress in increased oesophageal mucosa permeability and dilated intercellular spaces. Gut 56, 1191–1197 (2007). · DOI · Paper page
  160. Guadagnoli, L. et al. Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations.Neurogastroenterol. Motil. https://doi.org/10.1111/nmo.14081 (2021). · DOI
  161. de Bortoli, N. et al. Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: common overlapping gastrointestinal disorders. Ann. Gastroenterol. 31, 639–648 (2018).
  162. Omari, T. I. et al. Mechanisms of gastroesophageal reflux in healthy premature infants. J. Pediatr. 133, 650–654 (1998). · doi:10.1016/s0022-3476(98)70106-4
  163. Omari, T. I. et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease. Gut 51, 475–479 (2002). · doi:10.1136/gut.51.4.475
  164. Krishnan, U. et al. ESPGHAN-NASPGHAN guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with esophageal atresia-tracheoesophageal fistula. J. Pediatr. Gastroenterol. Nutr. 63, 550–570 (2016). · DOI · Paper page
  165. Arcos-Machancoses, J. V. et al. A systematic review with meta-analysis of the prevalence of gastroesophageal reflux in congenital diaphragmatic hernia pediatric survivors. Dis. Esophagus 31, dox158 (2018). · DOI
  166. Catalano, P., Di Pace, M. R., Caruso, A. M., Casuccio, A. & De Grazia, E. Gastroesophageal reflux in young children treated for esophageal atresia: evaluation with pH-multichannel intraluminal impedance. J. Pediatr. Gastroenterol. Nutr. 52, 686–690 (2011). · doi:10.1097/mpg.0b013e318202a3e5
  167. Pedersen, R. N. et al. Esophageal atresia: gastroesophageal functional follow-up in 5-15 year old children. J. Pediatr. Surg. 48, 2487–2495 (2013). · doi:10.1016/j.jpedsurg.2013.07.019
  168. Moayyedi, P., Talley, N. J., Fennerty, M. B. & Vakil, N. Can the clinical history distinguish between organic and functional dyspepsia? JAMA 295, 1566–1576 (2006). · DOI · Paper page
  169. Klauser, A. G., Schindlbeck, N. E. & Müller-Lissner, S. A. Symptoms in gastro-oesophageal reflux disease. Lancet 335, 205–208 (1990). · DOI · Paper page
  170. Moayyedi, P. & Axon, A. T. The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease. Am. J. Gastroenterol. 94, 3122–3125 (1999). · DOI
  171. Katz, P. O., Gerson, L. B. & Vela, M. F. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am. J. Gastroenterol. 108, 308–328 (2013). The American College of Gastroenterology guidelines for the diagnosis and treatment of GERD. · DOI · Paper page
  172. Muthusamy, V. R. et al. The role of endoscopy in the management of GERD. Gastrointest. Endosc. 81, 1305–1310 (2015). · DOI
  173. Johnsson, F., Joelsson, B., Gudmundsson, K. & Greiff, L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand. J. Gastroenterol. 22, 714–718 (1987). · doi:10.3109/00365528709011148
  174. Kahrilas, P. J., Shaheen, N. J. & Vaezi, M. F. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology 135, 1392–1413.e1-5 (2008). · DOI · Paper page
  175. Sifrim, D., Castell, D., Dent, J. & Kahrilas, P. J. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 53, 1024–1031 (2004). · DOI · Paper page
  176. Bredenoord, A. J., Weusten, B. L., Timmer, R., Conchillo, J. M. & Smout, A. J. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am. J. Gastroenterol. 101, 453–459 (2006). · DOI · Paper page
  177. Savarino, E. et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig. Liver Dis. 43, 542–547 (2011). · DOI · Paper page
  178. Frazzoni, M. et al. Impedance-pH monitoring for diagnosis of reflux disease: new perspectives. Dig. Dis. Sci. 62, 1881–1889 (2017). · DOI
  179. Johnston, B. T., Troshinsky, M. B., Castell, J. A. & Castell, D. O. Comparison of barium radiology with esophageal pH monitoring in the diagnosis of gastroesophageal reflux disease. Am. J. Gastroenterol. 91, 1181–1185 (1996).
  180. Saleh, C. M., Smout, A. J. & Bredenoord, A. J. The diagnosis of gastro-esophageal reflux disease cannot be made with barium esophagograms. Neurogastroenterol. Motil. 27, 195–200 (2015). · doi:10.1111/nmo.12457
  181. Saritas Yuksel, E. et al. Use of direct, endoscopic-guided measurements of mucosal impedance in diagnosis of gastroesophageal reflux disease. Clin. Gastroenterol. Hepatol. 10, 1110–1116 (2012). · DOI
  182. Katzka, D. A. et al. Endoscopic mucosal impedance measurements correlate with eosinophilia and dilation of intercellular spaces in patients with eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 13, 1242–1248.e1 (2015). · DOI
  183. Ates, F. et al. Mucosal impedance discriminates GERD from non-GERD conditions. Gastroenterology 148, 334–343 (2015). Mucosal impedance, a new technique for spot assessment of oesophageal mucosal integrity, enables an immediate diagnosis of GERD. · DOI
  184. Potluri, S. et al. Comparison of a salivary/sputum pepsin assay with 24-hour esophageal pH monitoring for detection of gastric reflux into the proximal esophagus, oropharynx, and lung. Dig. Dis. Sci. 48, 1813–1817 (2003). · doi:10.1023/a:1025467600662
  185. Saritas Yuksel, E. et al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope 122, 1312–1316 (2012). · DOI
  186. Hayat, J. O. et al. Objective detection of esophagopharyngeal reflux in patients with hoarseness and endoscopic signs of laryngeal inflammation. J. Clin. Gastroenterol. 48, 318–327 (2014). · DOI
  187. Spyridoulias, A., Lillie, S., Vyas, A. & Fowler, S. J. Detecting laryngopharyngeal reflux in patients with upper airways symptoms: Symptoms, signs or salivary pepsin? Respir. Med. 109, 963–969 (2015). · doi:10.1016/j.rmed.2015.05.019
  188. Sereg-Bahar, M., Jerin, A., Jansa, R., Stabuc, B. & Hocevar-Boltezar, I. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study. Clin. Otolaryngol. 40, 234–239 (2015). · DOI
  189. Kim, T. H., Lee, K. J., Yeo, M., Kim, D. K. & Cho, S. W. Pepsin detection in the sputum/saliva for the diagnosis of gastroesophageal reflux disease in patients with clinically suspected atypical gastroesophageal reflux disease symptoms. Digestion 77, 201–206 (2008). · doi:10.1159/000143795
  190. Ocak, E., Kubat, G. & Yorulmaz, İ. Immunoserologic pepsin detection in the saliva as a non-invasive rapid diagnostic test for laryngopharyngeal reflux. Balk. Med. J. 32, 46–50 (2015). · doi:10.5152/balkanmedj.2015.15824
  191. Yadlapati, R. et al. Abilities of oropharyngeal ph tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation. Clin. Gastroenterol. Hepatol. 14, 535–542.e2 (2016). · doi:10.1016/j.cgh.2015.11.017
  192. Lynch, C. R. et al. Effect of acid-suppressive therapy on narrow band imaging findings in gastroesophageal reflux disease: a pilot study. Dis. Esophagus 26, 124–129 (2013). · DOI
  193. Arul, P., Vinoth, B., Alexander, T., Phansalkar, M. & Padhi, S. Correlation of narrow band imaging endoscopy and histopathology in the diagnosis of nonerosive reflux disease. Saudi J. Gastroenterol. 21, 330–336 (2015). · doi:10.4103/1319-3767.164205
  194. Tseng, P. H. et al. Performance of narrow band imaging and magnification endoscopy in the prediction of therapeutic response in patients with gastroesophageal reflux disease. J. Clin. Gastroenterol. 45, 501–506 (2011). · DOI
  195. Orenstein, S. R. et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am. J. Gastroenterol. 95, 1422–1430 (2000). · doi:10.1111/j.1572-0241.2000.02073.x · Paper page
  196. Rosen, R. et al. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr. Pulmonol. 49, 1090–1096 (2014). · DOI
  197. Rosen, R., Lord, C. & Nurko, S. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin. Gastroenterol. Hepatol. 4, 167–172 (2006). · doi:10.1016/s1542-3565(05)00854-2
  198. Jadcherla, S. R. et al. Impact of feeding strategies on the frequency and clearance of acid and nonacid gastroesophageal reflux events in dysphagic neonates. J. Parenter. Enter. Nutr. 36, 449–455 (2012). · doi:10.1177/0148607111415980
  199. Mahoney, L. B., Nurko, S. & Rosen, R. The prevalence of rome IV nonerosive esophageal phenotypes in children. J. Pediatr. 189, 86–91 (2017). · DOI
  200. Metheny, N. A. et al. Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit. care Med. 34, 1007–1015 (2006). · DOI · Paper page

200 of 343 shown

Cited by

See all 237

Metadata

Authors
Fass, R., Boeckxstaens, G. E., El-Serag, H., Rosen, R., Sifrim, D., & Vaezi, M. F.
Venue
Nature Reviews Disease Primers
Published
2021-07-29
Volume
7
Issue
1
Pages
55-55
ISSN
2056-676X (ISSN-L)
OpenAlex
W3183515158
Cited by
237
References
5
FWCI
7.77
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastro-oesophageal reflux disease. https://app.cochat.ai/papers/10.1038/s41572-021-00287-w
The paper
Fass, R., Boeckxstaens, G. E., El-Serag, H., Rosen, R., Sifrim, D., & Vaezi, M. F. (2021). Gastro-oesophageal reflux disease. Nature Reviews Disease Primers. https://doi.org/10.1038/s41572-021-00287-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.